Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.
about
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain ManagementCombined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in miceModifying tetramethyl-nitrophenyl-imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy.Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain modelA Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.The cannabinoid system and pain.TRPV1-FAAH-COX: The Couples Game in Pain Treatment.Breaking barriers to novel analgesic drug development.Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritisThe monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.Clinical studies and anti-inflammatory mechanisms of treatments.Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats.Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice.Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction.
P2860
Q28067493-D25485DA-E6A5-4213-8A55-064BD66F8F61Q35223920-E2014DC1-1A2C-4437-8508-A4C7FDB04943Q35541709-855120E3-8033-40A1-9DDA-57F644F8AF18Q36576347-43BD2DA5-C9CA-4C77-8156-221E98E383B0Q36744213-7DEE1754-0F9A-4338-857D-5A62A1BB7E85Q36823364-946B4B05-18E0-4FE3-9463-689F0C30320FQ38600704-4DA1B83A-B492-475B-98E1-F23D8B2FB15AQ38669685-1F791B91-F53B-4C8C-A4BD-192AB9EF45AEQ38848349-B5C1ACF7-C0DB-4568-9930-76A6E61BCF39Q39360773-2C5BAD81-B90B-49B6-BE8D-DB7FC11A5E10Q41531870-12247399-7793-48E9-80E6-9BA73638163DQ45068836-8EEC5BA9-7B66-494B-948F-BF14DF0AFB40Q47124754-247AFAFE-8E4C-4634-A5AC-BD2C5FA507BCQ48298041-CEA0150C-FFF3-4D90-A52E-E28FE8816ABFQ52660821-053E0A2A-6D3D-4869-9CA0-C5CFC631D613Q55070207-A3C55EAB-EA8C-4660-8212-647D8E101FA0
P2860
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Combined inhibition of FAAH an ...... and inflammatory pain models.
@ast
Combined inhibition of FAAH an ...... and inflammatory pain models.
@en
Combined inhibition of FAAH an ...... and inflammatory pain models.
@nl
type
label
Combined inhibition of FAAH an ...... and inflammatory pain models.
@ast
Combined inhibition of FAAH an ...... and inflammatory pain models.
@en
Combined inhibition of FAAH an ...... and inflammatory pain models.
@nl
prefLabel
Combined inhibition of FAAH an ...... and inflammatory pain models.
@ast
Combined inhibition of FAAH an ...... and inflammatory pain models.
@en
Combined inhibition of FAAH an ...... and inflammatory pain models.
@nl
P2093
P2860
P1476
Combined inhibition of FAAH an ...... and inflammatory pain models.
@en
P2093
Aron H Lichtman
Steven G Kinsey
Sudeshna Ghosh
Travis W Grim
P2860
P304
P356
10.1016/J.PBB.2014.07.008
P407
P577
2014-07-21T00:00:00Z